Benlysta® is the first medicine specifically developed and approved for lupus and the first lupus therapy approved for lupus nephritis. It was developed by Human Genome Sciences (HGS) in partnership ...
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results